DNA Vaccines

Bradley, Eric S.; McNeel, Douglas G.

doi:10.1007/978-1-4419-0717-2_130

Cancer Therapeutic Targets 2017

DOI: 10.1007/978-1-4419-0717-2_130

|View full text |Cite

DNA Vaccines

Eric S. Bradley¹,

Douglas G. McNeel²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

et al. 2021

View full text Add to dashboard Cite

In recent years, vaccine development using ribonucleic acid (RNA) has become the most promising and studied approach to produce safe and effective new vaccines, not only for prophylaxis but also as a treatment. The use of messenger RNA (mRNA) as an immunogenic has several advantages to vaccine development compared to other platforms, such as lower coast, the absence of cell cultures, and the possibility to combine different targets. During the COVID-19 pandemic, the use of mRNA as a vaccine became more relevant; two out of the four most widely applied vaccines against COVID-19 in the world are based on this platform. However, even though it presents advantages for vaccine application, mRNA technology faces several pivotal challenges to improve mRNA stability, delivery, and the potential to generate the related protein needed to induce a humoral- and T-cell-mediated immune response. The application of mRNA to vaccine development emerged as a powerful tool to fight against cancer and non-infectious and infectious diseases, for example, and represents a relevant research field for future decades. Based on these advantages, this review emphasizes mRNA and self-amplifying RNA (saRNA) for vaccine development, mainly to fight against COVID-19, together with the challenges related to this approach.

show abstract

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

et al. 2021

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

DNA Vaccines

Cited by 1 publication

References 62 publications

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

Contact Info

Product

Resources

About